Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 950-953
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.950
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.950
Figure 1 Antitumor activity of Dox or PLD alone or in combi-nation with EBB in mice with hepatoma.
Figure 2 Dox concentrations in tumor tissues from mice after i.
v. injection of Dox (10 mg/kg) or PLD (equal to 10 mg/kg Dox) in combination with EBB (5 mg/kg).
Figure 3 Histopathological changes in livers of tumor-bearing mice treated with saline (A), Dox (B), Dox + EBB (C), PLD (D) or PLD + EBB (E).
(Original magnification, × 200).
Figure 4 IC50 value of Dox or PLD alone or in combination with EBB.
- Citation: Fang BJ, Yu ML, Yang SG, Liao LM, Liu JW, Zhao R-. Effect of O-4-ethoxyl-butyl-berbamine in combination with pegylated liposomal doxorubicin on advanced hepatoma in mice. World J Gastroenterol 2004; 10(7): 950-953
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.950